Page 129 - product-manual
P. 129

TM/MC  TM/MC
             REFERENCES (cont’d)








        Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB. (2005). Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for
        dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Archives of Pathology & Laboratory Medicine. 129:74-7.

        Mooney MA, Vaughn DM, Reinhart GA, et al. (1998).  Evaluation of the effects of omega-3 fatty acid-containing diets on the inflammatory stage of wound healing in dogs.
        American Journal of Veterinary Research. 59:859-63.

        Mozaffarian D, Rimm EB. (2006). Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 296:1885-99.

        National Research Council of the National Academics. (NRC). (2006). Nutrient Requirements of Dogs and Cats. Animal Nutrition Series. Washington (DC): The National
        Academies Press.

        National Research Council. (1987). Vitamin Tolerance of Animals. Washington (DC): The National Academies Press.

        Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. (2000). Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a
        double-blind, randomized placebo-controlled study. Cancer. 88:1916-28.

        Pakala R, Pakala R, Radcliffe JD, Benedict CR. (1999). Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids.
        Prostaglandins, Leukotrienes, and Essential Fatty Acids. 60:115-23.

        Popa I, Pin D, Remoué N, et al. (2011). Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed
        supplement. A pilot study. Veterinary Research Communications. 35:501-9.

        Ramadeen A, Laurent G, dos Santos CC, et al. (2010). n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial
        cardiomyopathy. Heart Rhythm. 7:520-8.

        Re S, Zanoletti M, Emanuele E. (2008). Aggressive dogs are characterized by low omega-3 polyunsaturated fatty acid status. Veterinary Research Communications. 32:225-
        30.

        Roudebush P, Polzin DJ, Adams LG, et al. (2010). An evidence-based review of therapies for canine chronic kidney disease. The Journal of Small Animal Practice. 51:244-52.

        Roush JK, Cross AR, Renberg WC, et al. (2010). Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with
        osteoarthritis. Journal of American Veterinary Medical Association. 236:67-73.

        Roush JK, Dodd CE, Fritsch DA, et al. (2010). Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Journal of the
        American Veterinary Medical Association. 236:59-66.

        Szabo J, Ibrahim WH, Sunvold GD, Bruckner GG. (2003). Effect of dietary protein quality and essential fatty acids on fatty acid composition in the liver and adipose tissue
        after rapid weight loss in overweight cats. American Journal of Veterinary Research. 64:310-5.

        Szabo J, Ibrahim WH, Sunvold GD, et al. (2000). Influence of dietary protein and lipid on weight loss in obese ovariohysterectomized cats. American Journal of Veterinary
        Research. 61:559-65.

        Taha AY, Henderson ST, Burnham WM. (2009). Dietary enrichment with medium chain triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of
        aged dogs: implications for treating age-related cognitive decline. Neurochemical Research. 34:1619-25.

        Vaddadi KS. (1981). The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia.
        Prostaglandins and Medicine. 6: 375-9.









        8  |   Omega3/6/9 -VM TM
   124   125   126   127   128   129   130   131   132   133   134